Key result
Verapamil treatment in rats reduced infarct size by 20% at 5 hours and 12% at 24 hours after coronary occlusion, but was associated with large postoperative mortality.
Why the study?
Does verapamil reduce infarct size in a rat model of myocardial infarction?
Does verapamil reduce infarct size in a rat model of myocardial infarction?
TTC staining provides reliable demarcation of infarct size in rats, and while verapamil reduces infarct size in this model, high mortality and nonuniform infarcts complicate translation to clinical trials.
Answers are grounded in this paper and cite their sources.
Verapamil-associated mortality in rat MI models cautions against translation; leaves open whether refined dosing extends infarct-size benefits.
The feasibility of measuring the extent of hypoperfused myocardium and the infarct size was examined in rat hearts after occlusion of the left coronary artery. The extent of hypoperfused myocardium was examined by autoradiography and after perfusion with fluorescent microspheres. Both methods appeared unreliable in this model. Triphenyltetrazolium chloride (TTC) staining, however, provided a distinct demarcation line between viable myocardium, which was stained red, and the necrotic myocardium, consistent with the ultrastructural border between normal and severely damaged myocytes 5 h after coronary occlusion. TTC staining gives the best demarcation of ischemic tissues. In verapamil-treated rats, there was an apparent reduction in infarct size as compared with untreated rats; 20% reduction in infarct size 5 h after coronary occlusion and 12% reduction after 24 h. There was, however, a large postoperative mortality among the verapamil-treated rats. These problems, and the nonuniform infarct size in rats, may in part explain why infarct size limitation by verapamil has been reported from rat experiments, but not from clinical trials.
No takes yet. Share an insight, caveat, or question.
Greve et al. (1991) studied Myocardial infarction. Verapamil vs. Untreated rats was evaluated on Infarct size (20% reduction at 5 h, 12% reduction at 24 h). Verapamil treatment in rats reduced infarct size by 20% at 5 hours and 12% at 24 hours after coronary occlusion, but was associated with large postoperative mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: